Suppr超能文献

基底细胞癌的皮肤镜检查 第3部分:鉴别诊断、治疗监测及新技术

Dermoscopy of Basal Cell Carcinoma Part 3: Differential Diagnosis, Treatment Monitoring and Novel Technologies.

作者信息

Wojtowicz Irena, Żychowska Magdalena

机构信息

Department of Dermatology, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszów, Poland.

出版信息

Cancers (Basel). 2025 Mar 19;17(6):1025. doi: 10.3390/cancers17061025.

Abstract

Basal cell carcinoma (BCC) is the most frequently diagnosed skin cancer globally. Despite the well-established dermoscopic features of BCC, overlapping characteristics with other benign and malignant skin conditions cause challenges in differential diagnosis. Part III of this review highlights the role of dermoscopy in differential diagnosis, treatment planning, therapy monitoring and the integration of novel technologies including ultraviolet-induced fluorescence dermoscopy (UVFD) and optical super-high magnification dermoscopy (OSHMD). A search of the PubMed database was conducted for studies reporting on advances in the dermoscopic assessment of BCC, including differential diagnosis, treatment, monitoring and novel diagnostic technologies. Even entities with well-defined dermoscopic features distinguishing them from BCC can sometimes mimic BCC. Additionally, rare lesions such as neurothekeoma, reticulohistiocytoma, solitary circumscribed neuroma, dermal leiomyosarcoma and various adnexal tumors often remain dermoscopically indistinguishable from BCC, which underscores the importance of histopathology as the diagnostic gold standard. Dermoscopy aids in delineating the tumor margins, optimizing Mohs micrographic surgery (MMS) and traditional excision. It may also help to monitor therapeutic effects by detecting the disappearance of BCC patterns, the presence of residual tumor or recurrences. Dermoscopy may aid in the prediction of therapeutic responses to imiquimod, photodynamic therapy or vismodegib. UVFD and OSHMD appear to be valuable complementary diagnostic techniques for detecting BCC. UVFD seems to be particularly valuable for the detection of small tumors (<5 mm), facial lesions and nodular or non-pigmented BCC subtypes, while OSHMD is useful for the assessment of superficial and non-pigmented BCCs. Three-dimensional total-body photography enhances diagnostic precision but, so far, only when used in combination with traditional dermoscopy. Dermoscopy is valuable for margin delineation, therapy monitoring and differential diagnosis but can be inconclusive, which highlights the role of histopathology as the gold standard. Modifications in dermoscopy technique may further enhance its accuracy.

摘要

基底细胞癌(BCC)是全球最常被诊断出的皮肤癌。尽管BCC具有已明确的皮肤镜特征,但与其他良性和恶性皮肤疾病的重叠特征给鉴别诊断带来了挑战。本综述的第三部分重点介绍了皮肤镜在鉴别诊断、治疗规划、治疗监测以及包括紫外线诱导荧光皮肤镜(UVFD)和光学超高倍皮肤镜(OSHMD)在内的新技术整合中的作用。在PubMed数据库中进行了检索,以查找报告BCC皮肤镜评估进展的研究,包括鉴别诊断、治疗、监测和新型诊断技术。即使是具有明确皮肤镜特征可与BCC区分的实体,有时也可能模仿BCC。此外,罕见病变如神经鞘瘤、网状组织细胞瘤、孤立性局限性神经瘤、皮肤平滑肌肉瘤和各种附属器肿瘤在皮肤镜下通常与BCC难以区分,这突出了组织病理学作为诊断金标准的重要性。皮肤镜有助于勾勒肿瘤边缘,优化莫氏显微外科手术(MMS)和传统切除术。它还可能通过检测BCC模式的消失、残留肿瘤的存在或复发来帮助监测治疗效果。皮肤镜可能有助于预测对咪喹莫特、光动力疗法或维莫德吉的治疗反应。UVFD和OSHMD似乎是检测BCC的有价值的辅助诊断技术。UVFD对于检测小肿瘤(<5mm)、面部病变以及结节性或无色素性BCC亚型似乎特别有价值,而OSHMD可用于评估浅表性和无色素性BCC。三维全身摄影可提高诊断精度,但到目前为止,仅在与传统皮肤镜结合使用时才有效。皮肤镜对于边缘勾勒、治疗监测和鉴别诊断很有价值,但可能不具有决定性,这突出了组织病理学作为金标准的作用。皮肤镜技术的改进可能会进一步提高其准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a1/11940417/22a08e5ae4e1/cancers-17-01025-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验